◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › PODD

Insulet Corporation (PODD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-07-19

Insulet Corporation (PODD) operates in the Health Care Equipment industry and is headquartered in Acton, United States with about 5,400 employees. Its market capitalization is roughly $11 billion. In the fiscal year ended 2025-12-31, PODD reported $2.7B in revenue and $247M in net income.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

Interactive charts & full statements → Open the PODD valuation workbench →

PODD Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$2.9B	$2.7B	$2.1B	$1.7B	$1.3B	$1.1B	$904M	$738M	$564M	$464M	$367M	$264M	$289M	$247M	$211M	$152M	$97M	$66M	$36M	$13M	$4M
Gross Profit	$2.1B	$1.9B	$1.4B	$1.2B	$806M	$752M	$582M	$480M	$370M	$277M	$211M	$133M	$143M	$112M	$92M	$67M	$44M	$18M	($5M)	($12M)	($12M)
Gross Margin %	71.0%	71.6%	69.8%	68.3%	61.7%	68.5%	64.4%	65.1%	65.6%	59.8%	57.5%	50.5%	49.6%	45.5%	43.7%	43.8%	45.1%	27.7%	-12.7%	-92.4%	-327.5%
Operating Income (EBIT)	$507M	$474M	$309M	$220M	$38M	$126M	$52M	$50M	$27M	($7M)	($11M)	($49M)	($12M)	($29M)	($36M)	($42M)	($39M)	($59M)	($89M)	($54M)	($35M)
Operating Margin %	17.5%	17.5%	14.9%	13.0%	2.9%	11.5%	5.7%	6.8%	4.9%	-1.6%	-2.9%	-18.5%	-4.3%	-11.8%	-17.0%	-27.9%	-39.8%	-89.9%	-247.8%	-402.7%	-945.8%
Net Income	$303M	$247M	$418M	$206M	$5M	$17M	$7M	$12M	$3M	($27M)	($29M)	($74M)	($52M)	($45M)	($52M)	($57M)	($61M)	($80M)	($93M)	($54M)	($36M)
Net Margin %	10.4%	9.1%	20.2%	12.2%	0.4%	1.5%	0.8%	1.6%	0.6%	-5.8%	-7.9%	-27.9%	-17.8%	-18.2%	-24.5%	-37.5%	-63.1%	-120.5%	-257.3%	-400.4%	-981.4%
EBITDA	$575M	$532M	$424M	$324M	$109M	$140M	$110M	$74M	$43M	$6M	$1M	($33M)	$0M	($17M)	($25M)	($28M)	($33M)	($54M)	($75M)	($49M)	($32M)
Earnings Per Share (EPS)	$4.29	$3.44	$5.66	$2.80	$0.07	$0.24	$0.10	$0.19	$0.05	$-0.46	$-0.50	$-1.29	$-0.93	$-0.83	$-1.08	$-1.22	$-1.54	$-2.68	$-3.36	$-3.21	$-39.19
Shares Outstanding (M)	70M	72M	74M	74M	70M	69M	66M	62M	61M	58M	57M	57M	56M	54M	48M	47M	40M	30M	28M	17M	1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PODD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$762M	$784M	$706M	$649M	$569M	$598M	$544M	$488M
Gross Profit	$529M	$569M	$510M	$452M	$409M	$431M	$377M	$331M
Gross Margin %	69.5%	72.5%	72.2%	69.7%	71.9%	72.1%	69.3%	67.7%
Operating Income (EBIT)	$122M	$146M	$118M	$121M	$89M	$109M	$88M	$54M
Operating Margin %	16.0%	18.7%	16.7%	18.7%	15.6%	18.3%	16.2%	11.2%
Net Income	$91M	$102M	$88M	$22M	$35M	$101M	$78M	$189M
Net Margin %	12.0%	13.0%	12.4%	3.5%	6.2%	16.9%	14.2%	38.6%
EBITDA	$154M	$190M	$160M	$70M	$79M	$142M	$116M	$81M
Earnings Per Share (EPS)	$1.30	$1.44	$1.24	$0.32	$0.48	$1.36	$1.05	$2.56
Shares Outstanding (M)	70M	71M	71M	71M	74M	74M	74M	74M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PODD Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$619M	$569M	$430M	$146M	$119M	($68M)	$84M	$98M	$36M	$41M	$16M	($13M)	$9M	$3M	($29M)	($25M)	($36M)	($49M)	($83M)	($50M)	($32M)
Capital Expenditures (CapEx)	$207M	$192M	$125M	$76M	$157M	$123M	$166M	$171M	$162M	$77M	$22M	$11M	$11M	$7M	$11M	$11M	$7M	$3M	$10M	$10M	$13M
Free Cash Flow (FCF)	$412M	$378M	$305M	$70M	($38M)	($191M)	($82M)	($72M)	($126M)	($36M)	($6M)	($23M)	($3M)	($4M)	($40M)	($37M)	($42M)	($52M)	($93M)	($60M)	($45M)
FCF Margin %	14.2%	14.0%	14.7%	4.1%	-2.9%	-17.4%	-9.1%	-9.8%	-22.4%	-7.8%	-1.7%	-8.8%	-0.9%	-1.6%	-18.9%	-24.0%	-43.5%	-79.5%	-257.0%	-452.1%	-1227.3%
Dividends Paid	—	—	—	$11M	—	$24M	$98M	$9M	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PODD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$114M	$183M	$126M	$196M	$64M	$148M	$98M	$87M
Capital Expenditures (CapEx)	$28M	$135M	$21M	$23M	$12M	$56M	$27M	$22M
Free Cash Flow (FCF)	$86M	$48M	$105M	$173M	$52M	$92M	$72M	$64M
FCF Margin %	11.3%	6.2%	14.8%	26.7%	9.0%	15.3%	13.2%	13.2%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PODD Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$3.0B	$3.2B	$3.1B	$2.6B	$2.3B	$2.0B	$1.9B	$1.1B	$929M	$817M	$457M	$275M	$302M	$288M	$198M	$210M	$156M	$172M	$109M	$131M	$57M
Cash & Cash Equivalents	$480M	$716M	$953M	$651M	$624M	$792M	$948M	$376M	$114M	$440M	$137M	$123M	$151M	$150M	$94M	$94M	$113M	$128M	$57M	$95M	$33M
Total Liabilities	$1.7B	$1.7B	$1.9B	$1.9B	$1.8B	$1.5B	$1.3B	$1.1B	$717M	$658M	$393M	$241M	$218M	$163M	$154M	$138M	$90M	$119M	$105M	$38M	$159M
Total Debt (Short + Long-Term)	$948M	$953M	$1.4B	$1.4B	$1.4B	$1.3B	$1.1B	$892M	$592M	$1.1B	$333M	$177M	$172M	$116M	$118M	$122M	$69M	$89M	$85M	$27M	$29M
Total Shareholders' Equity	$1.3B	$1.5B	$1.2B	$733M	$476M	$556M	$604M	$76M	$212M	$159M	$63M	$34M	$84M	$125M	$44M	$71M	$66M	$53M	$4M	$92M	($102M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PODD viewer.

Other Companies in Health Care Equipment

STE · Steris — $21 billion
ZBH · Zimmer Biomet — $18 billion
RVTY · Revvity — $12 billion
BAX · Baxter International — $12 billion
ABT · Abbott Laboratories — $180 billion
SYK · Stryker Corporation — $127 billion
ISRG · Intuitive Surgical — $121 billion
MDT · Medtronic — $107 billion

← PODC All stocks POET →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.